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ABSTRACT
Involvement of the digestive system in AIDS pathologies or injuries is frequent. Aiming at 
comparing the frequency, the importance that these lesions have for death and the survival time 
in patients using or not using HAART, we studied 322 necropsies classified as follows: Group 
A – without antiretroviral drugs (185 cases); B – one or two antiretroviral drugs or HAART 
for less than six months (83 cases); C – HAART for six months or longer (54 cases). In the 
overall analysis of the digestive system, changes were present in 73.6% of cases. The most 
frequent was Candida infection (22.7%), followed by cytomegalovirus (19.2%), Histoplasma 
capsulatum (6.5%), mycobacteria (5.6%), and Toxoplasma gondii (4.3%). T. gondii infection 
was more frequent in group A compared with group C, and cytomegalovirus (CMV) was 
more frequent in group A compared with groups B and C (p < 0.05); 2.2% of the deaths were 
due to gastrointestinal bleeding. Regarding the segments, only in the large intestine, and only 
cytomegalovirus, were more frequent in group A compared with group C. We conclude that 
digestive system infections are still frequent, even with the use of HAART. However, the 
average survival time in group C was more than three times greater than the one in group A 
and nearly double that of group B, demonstrating the clear benefit of this therapy. 
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INTRODUCTION
The digestive system is considered a “sanctuary” for the Human Immunodeficiency 
Virus (HIV) infection, being an organ with abundant lymphoid tissue, where the CD4 
T lymphocytes and macrophages of the lamina propria are target cells for the viral 
infection. Active viral replication was observed in the intestinal lymphoid tissue of 
patients receiving antiretroviral therapy whose viral load was undetectable in the 
peripheral blood, suggesting that the digestive system is an important reservoir of 
HIV-infected cells, contributing to viral persistence1. The term HIV enteropathy 
refers to clinical, morphological and functional changes that affect infected patients 
from the acute phase to the late stages of the disease. These changes include diarrhea, 
increased intestinal mononuclear cell infiltration, increased intestinal permeability, 
malabsorption of bile acids and vitamin B12. These changes take place in the 
absence of fungal, bacterial or viral opportunistic infections. It is possible that HIV 
itself, through toxic or immune-mediated effects, is responsible for the enteropathy 
in these individuals2. In addition to HIV enteropathy, opportunistic infections and 
Guimarães et al.
Rev Inst Med Trop São Paulo. 2017;59:e3Page 2 of 11
tumors are common causes of impairment of the digestive 
system in patients with Acquired Immunodeficiency 
Syndrome (AIDS)3,4,5. From the status of an invariably fatal 
disease at the beginning of the pandemic, AIDS has gone 
through several phases of clinical expression and prognosis, 
mainly due to discoveries regarding the virus itself and 
the physiopathology, allowing therapeutic advances that 
have resulted in major changes in the natural history of 
the disease6. The introduction of antiretroviral drugs in the 
Highly Active Antiretroviral Therapy (HAART), permits, 
currently, a prolonged survival and reduced incidence of 
opportunistic infections and neoplasms7. Although damage 
to the digestive system is common in AIDS, we did not find 
necropsy studies comparing the changes of this system in 
pre and post-HAART phases. 
This study aimed at comparing the frequency of 
digestive system injuries in necropsies of patients with 
AIDS before and after HAART, the importance of these 
lesions for death and the survival time in patients using or 
not using HAART. Despite the global trend of reducing the 
number of necropsies due to an increased use of radiological 
and laboratory tests in pre-mortem diagnosis, necropsy 
remains important even today, as the discrepancy rates 
between pre-mortem and postmortem findings in AIDS vary 
from 42 to 74%. Despite significant advances in diagnostic 
procedures, false-positive and false-negative diagnosis in 
the absence of necropsy still exist8,9,10,11,12. Necropsies are 
essential procedures for the quality control in university 
hospitals, and have helped to further understanding of the 
most frequent diseases in patients with HIV/AIDS13. 
MATERIALS AND METHODS
This is a retrospective study of the digestive system 
in necropsies of individuals with HIV/AIDS held in the 
Department of Special Pathology/ Surgical Pathology 
Service of the Clinical Hospital of the Universidade 
Federal do Triângulo Mineiro (UFTM) from January 
1989 to December 2012. This study was approved by the 
Research Ethics Committee (CEP) of the UFTM (CEP/
UFTM protocol No. 1871). Necropsies of individuals over 
13 years of age diagnosed with AIDS, in life or postmortem, 
according to the 1993 Centers for Disease Control and 
Prevention (CDC) criteria of HIV infection classification, 
composed the study group14. The study excluded cases 
of necropsies that had no microscopic sampling of the 
digestive system and those whose medical records were 
not available for analysis. 
After macroscopic examination during the autopsy, 
samples of digestive system segments (tongue, esophagus, 
stomach, small intestine, and large intestine) were collected, 
fixed in 10% formaldehyde and processed for inclusion in 
paraffin. The standardization of samples for microscopy 
of the digestive system in our service consists in preparing 
at least one block containing fragments of each segment 
without macroscopic changes, as well as fragments of the 
lesions. Subsequently, histological sections were prepared 
from these samples and stained by the hematoxylin-eosin 
technique (HE). 
The diagnosis of lesions found in the digestive system 
was made by the first author of the study, through the review 
of archived histological slides; when necessary, additional 
slides were prepared. When relevant, we proceeded 
applied special histochemical staining techniques for the 
identification of infectious agents or review of them: Fite-
Faraco for mycobacteria; Grocott, PAS, and mucicarmin 
for fungi. When indicated, an immunohistochemical study 
(polymer technique) was carried out, or a review of the 
slides previously prepared for microbiological confirmation: 
anti-toxoplasma (Novocastra-NCL-TG-TP3) 1: 1,200; anti-
cytomegalovirus (Novocastra-NCL-CMV-pp65) 1: 200; anti-
herpes simplex virus (HSV Dako Type I and Type II) 1:2,000; 
anti-papillomavirus (BVP-1-Dako) 1:800; and to confirm 
neoplasms: anti-CD34 (Biocare Medical-CD34) 1:600 and 
anti-CD117 (Zeta corporation-CD117-YR145) 1:600. 
Despite the macroscopic standardization, there were 
not histological sections of all segments of the digestive 
system in all the cases, the results being presented as 
absolute numbers and percentages of the total number of 
cases evaluated in each segment of the digestive system.
We consider HAART to be the use of at least three 
drugs (two reverse transcriptase inhibitors associated with a 
protease inhibitor or a non-nucleoside reverse transcriptase 
inhibitor). In our service, HAART was introduced for 
the treatment of AIDS patients in 1997. However, due to 
the heterogeneity in the use of HAART from that period, 
patients were classified into three groups: A – without 
the use of any antiretroviral drug; B – using one or two 
antiretroviral drugs for any time or on HAART for less 
than six months; C – on HAART during the last six months 
or more. Even after the beginning of HAART, there were 
untreated patients filling group A and patients with a non 
suppressive treatment, included in group B. We considered 
the period of six months of HAART treatment because, 
according to the literature15,16, less than six months of use 
would be insufficient to improve immunity.
The survival time was measured in months after the 
initial diagnosis of HIV infection, confirmed by serology. 
The cases in which the diagnosis of HIV infection was 
made during hospitalization that preceded the death, or 
from blood samples collected at necropsy, were considered 
as zero survival.
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The changes found in the three groups of patients were 
compared by statistical analysis using the Chi-square test 
(x2), or Fisher’s exact test, using the GraphPad InStat 
program. The statistical analysis of the survival time was 
performed using the Kaplan-Meier test with IBM SPSS 
Advanced Statistics program. The significance level for all 
the tests was 5% (p < 0.05). 
Disease of the digestive system was considered relevant 
to the death when it was indicated as the immediate cause 
of death or a contributing cause to death. These cases were 
analyzed separately and their ratio was calculated in relation 
to other patients.
Finally, we elaborated a form for clinical reports obtained 
from medical records and the requests for necropsies, which 
contained the case number, sex and age of the patient, 
whether they had AIDS or not, use or not of antiretroviral 
medication (study group), morphological data obtained by the 
microscopic review of each segment of the digestive system, 
cause of death given on the necropsy report, and the survival 
time after diagnosis of HIV infection.
RESULTS
In the 1989-2012 period 355 necropsies of patients with 
HIV/AIDS were performed at the UFTM (18% of the total 
number of necropsies). This study included 322 necropsies 
of individuals with AIDS. The 33 excluded cases were: 3 
younger than 13 years old; 9 were HIV positive but did not 
meet the AIDS criteria; 20 cases had no histological slides 
of the digestive system available for review; in 1 case the 
medical records for review and data collection were not found. 
The average age of patients was 36.7 ± 11 years with 
a median of 35 years; there was a slight increase when 
comparing the 1989-1996 period (34.2 ± 11.5 years) to the 
1997-2012 (37.6 ± 10.7) one. Regarding the distribution 
by sex, a sharp rise was noted in the percentage of women 
when comparing the 1989-1996 period to the 1997-2012 
one (18.8% versus 33.2%). 
Considering the use of antiretroviral medication, 
monotherapy was introduced at the UFTM in 1993, and 
HAART in 1997. Although only 90 of the 322 cases were 
diagnosed prior to 1997 (and were part of a previously 
published study17), most patients (185 cases; 57.4%) in 
this study had no antiretroviral therapy, filling the criteria 
of group A; 83 (25.8%) were enrolled in group B; and only 
54 (16.8%) cases were included in group C. Table 1 shows 
the distribution of the 322 cases by age and sex  according 
to the study group.
Two hundred and thirty-seven cases (73.6%) had 
changes in some segment of the digestive system. Table 2 
compares the frequency of injuries in the digestive system 
in the different study groups.
The AIDS-related injuries (194 cases; 81.9%) were 
the most common changes, with a predominance of 
opportunistic infections (166 cases, 70%) in relation to 
neoplasms (5 cases of Kaposi’s sarcoma, 2.1%). Other 
infectious diseases, neoplasms and conditions not related to 
AIDS were present in 43 (18.1%) cases. The main changes 
Table 1 - Distribution of the 322 necropsies of AIDS patients, according to age, sex and the study group
Group A B C Total
Average age 37.5 ± 11.8 35.4 ± 10.3 35.7 ± 9.2 36.7 ± 11
Min.‑max. age 18‑72 17‑67 20‑61 17-72
Male 135 (73%) 61 (73.5%) 32 (59.3%) 228 (71%)
Female 50 (27%) 22 (26.5%) 22 (40.7%) 94 (29%)
Number of cases 185 (57.4%) 83 (25.8%) 54 (16.8%) 322 (100%)
Group A: without any antiretroviral medication; Group B: 1 or 2 antiretroviral drugs for any time or on HAART for less than the last 
six months; Group C: HAART in the last 6 months or more; Min.: minimum; Max.: maximum.
Table 2 - Distribution of cases according to the presence or absence of injuries in the digestive system, according to the study 
groups
Group A Group B Group C Total
With injuries 139 (75.1%) 61 (73.5%) 37 (68.5%) 237 (73.6%) 
Without injuries 46 (24.9%) 22 (26.5%) 17 (31.5%) 85 (26.4%)
Total 185 (100%) 83 (100%) 54 (100%) 322 (100%)
Group A: without any antiretroviral medication; Group B: 1 or 2 antiretroviral drugs for any time or on HAART for less than the 
last six months; Group C: HAART in the last 6 months or more. X2 test; p > 0.05.
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found in the digestive system are presented in Table 3. 
Considering all the segments of the digestive 
system, candidiasis was the most frequent abnormality 
(22.7%), followed by cytomegalovirus infection (19.2%), 
histoplasmosis (6.5%), mycobacterial infection (5.6%), 
and toxoplasmosis (4.3%). T. gondii infection was 
more frequent in group A compared with group C, and 
cytomegalovirus (CMV) was more frequent in group A 
compared with groups B and C (p < 0.05).
Culture was not performed for mycobacteria species 
identification; however, in 9 of the 18 cases, the 
morphological appearance was suggestive of Mycobacterium 
tuberculosis. Helminths were found in 20 cases, and in one 
of them there was simultaneous infestation by S. stercoralis 
and A. lumbricoides. 
Relevant neoplasms were present in 11 cases: 5 Kaposi’s 
sarcomas, 3 of them disseminated in the digestive system; 
3 GIST (gastrointestinal stromal tumor), and 3 carcinomas 
(1 gastric signet ring cell adenocarcinoma, 1 metastatic 
undifferentiated carcinoma of the testis, 1 rectal squamous 
cell carcinoma). There were no cases of lymphoma in the 
digestive system in this study.
Analyzing each segment of the digestive system 
separately, in the tongue changes were observed in 78 
(55.7%) of the 140 cases in which it was possible to analyze 
the organ microscopically. The main changes are presented 
in Table 4. Candidiasis was the most frequent lesion; 
however, there was no statistically significant difference 
among groups. No tumors were found in the tongue. 
Regarding the esophagus, lesions were observed in 142 
Table 3 - Main morphological changes in the digestive system of the 322 necropsies of AIDS patients, according to the study 
group
Group A (n=185) Group B (n=83) Group C (n=54) Total (n=322)
(n) % (n) % (n) % (n) %
INFECTIOUS AGENT
Protozoa
T. gondii 13* 7 1 1.2 0 0 14 4.3
Cryptosporidium 2 1 0 0 1 1.8 3 0.9
Isospora 1 0.5 0 0 0 0 1 0.3
Fungi
Candida 48 26 16 19.3 9 16.6 73 22.7
H. capsulatum 14 7.5 4 4.8 3 5.5 21 6.5
C. neoformans 8 4.3 3 3.6 1 1.8 12 3.7
P. brasiliensis 2 1 0 0 1 1.8 3 0.9
Bacteria
Mycobacteria 15 8.1 2 2.4 1 1.8 18 5.6
Virus
CMV 49a b 26.4 7a 8.4 6b 11.1 62 19.2
HSV 6 3.2 3 3.6 1 1.8 10 3.1
Helminths
S. stercoralis 7 3.8 2 2.4 4 7.4 13 4
A. lumbricoides 2 1 2 2.4 0 0 4 1.2
Taenia 2 1 1 1.2 0 0 3 0.9
S. mansoni 1 0.5 1 1.2 0 0 2 0.6
NEOPLASMS
Karposi’s sarcoma 2 1 1 1.2 2 3.7 5 1.5
Carcinoma 1 0.5 2 2.4 0 0 3 0.9
GIST 0 0 2 2.4 1 1.8 3 0.9
Multiple infectious agents were simultaneously observed in some cases. Group A: without any antiretroviral medication; Group B: 
1 or 2 antiretroviral drugs for any time or on HAART for less than the last six months; Group C: HAART in the last 6 months or more; 
CMV: cytomegalovirus; HSV: Herpes simplex virus; GIST: gastrointestinal stromal tumor. Fisher’s exact test; *p < 0.05 between the 
study groups A and C; a p < 0.05 between the study groups A and B; b p < 0.05 between the study groups A and C. 
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(52%) of the 273 cases in which analysis was possible. The 
main changes were infectious and they are shown in Table 5; 
however, there was no statistically significant difference 
between the frequencies of the different injuries among 
the study groups. Two cases of chagasic megaesophagus 
were found and there was no reactivation of Chagas disease.
Considering the stomach, the microscopic analysis was 
possible in 303 of the 322 cases, finding changes in 104 
(34.3%) cases. The main changes are presented in Table 6; 
CMV infection was the most frequent lesion in the stomach; 
however, there was no statistically significant difference 
among groups. 
Regarding the small intestine, the microscopic analysis 
was possible in 306 cases, observing changes in 79 (25.8%). 
Table 4 - Main morphological changes in 140 necropsies of AIDS patients in whom it was possible to analyze the tongue, according 
to the study group
Tongue injuries Group A (n=82) Group B (n=41) Group C (n=17) Total (n=140)(n) % (n) % (n) % (n) %
Candidiasis 27 32.9 10 24.4 8 47 45 32.1
Oral pilar leukoplasia 8 9.7 6 14.6 1 5.9 15 10.7
Histoplasmosis 5 6.0 0 0 0 0 5 3.6
Cryptococcosis 2 2.4 0 0 0 0 2 1.4
CMV infection 1 1.2 0 0 0 0 1 0.7
Herpetic infection 1 1.2 0 0 0 0 1 0.7
Mycobacterial infection 1 1.2 0 0 0 0 1 0.7
Toxoplasmosis 1 1.2 0 0 0 0 1 0.7
Paracoccidioidomycosis 1 1.2 0 0 0 0 1 0.7
Concomitant lesions were present in 6 cases. Group A: without any antiretroviral medication; Group B: 1 or 2 antiretroviral drugs 
for any time or on HAART for less than the last six months; Group C: HAART in the last 6 months or more; n: number of cases; 
CMV – cytomegalovirus. X2 test; p > 0.05. 
Table 5 - Main morphological changes in 273 necropsies of AIDS patients in whom it was possible to analyze the esophagus, 
according to the study group
Esophagus injuries Group A (n=157) Group B (n=68) Group C (n=48) Total (n=273)(n) % (n) % (n) % (n) %
INFECTION
Candidiasis 26 16.5 7 10.3 4 8.3 37 13.5
CMV infection 23 14.6 7 10.3 5 10.4 35 12.8
Herpetic infection 5 3.2 3 4.4 1 2 9 3.3
Histoplasmosis 4 2.5 0 0 2 4.1 6 2.2
Cryptococcosis 3 2 1 1.5 1 2 5 1.8
Mycobacterial infection 4 2.5 0 0 0 0 4 1.5
Toxoplasmosis 4 2.5 0 0 0 0 4 1.5
Chagasic megaesophagus 1 0.6 0 0 1 2 2 0.7
NEOPLASMS
Karposi’s sarcoma 1 0.6 1 1.5 0 0 2 0.7
Carcinoma 0 0 1 1.5 0 0 1 0.4
Squamous papilloma 0 0 0 0 1 2 1 0.4
NONINFECTIOUS 
EROSIONS/ULCERS 
10 6.4 3 4.4 6 12.5 19 7
Concomitant lesions were present in 13 cases. Group A: without any antiretroviral medication; Group B: 1 or 2 antiretroviral drugs 
for any time or on HAART for less than the last six months; Group C: HAART in the last 6 months or more; CMV‑ cytomegalovirus. 
X2 test; p > 0.05.
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The main changes are presented in Table 7; cytomegalovirus 
infection and histoplasmosis were the most common 
injuries in this segment; however, there was no statistically 
significant difference among groups.
Considering the large intestine, lesions were observed 
in 123 (41%) of the 301 cases in which microscopic 
analysis was possible. The main changes are presented in 
Table 8; CMV infection was more frequent in group A in 
comparison with group C (p < 0.05). One case of chagasic 
megacolon was found, but it did not present reactivation 
of Chagas disease.
This study also evaluated whether the changes of the 
digestive system were relevant to death, which occurred 
in 14 (4.3%) cases. In 7 (2.2%) of them, the immediate 
cause of death was hypovolemic shock secondary to 
gastrointestinal bleeding, and in the other 7 cases, the 
digestive system lesions have contributed to death.
Regarding the survival time and the use or not of 
HAART, the analysis was performed in 297 (92%) of the 
322 cases (Figure 1). The Kaplan-Meier test showed a better 
survival rate in group C compared to the other groups, and 
this difference was statistically significant, showing a clear 
benefit of HAART. 
DISCUSSION
Considering PubMed (www.ncbi.nlm.nih.gov/pubmed) 
as a research source, this seems to be the first study of 
necropsies in AIDS patients that compares morphological 
changes of the digestive system pre- and post-HAART. 
The main advantage of necropsy is that it enables a broad 
analysis of the digestive system segments, despite the 
presence of mucosa autolysis.
In this study, an increase in the percentage of the female 
population with AIDS was observed, from 18.8% in the 
1989-1996 period to 33.2% in the 1997-2012 period, a 
feature described as the phenomenon of feminization of 
the disease18. The feminization of AIDS is related to the 
increase in heterosexual transmission of HIV observed in 
recent years of the epidemic19.
The damage to the digestive system in this study was 
present in 73.6% of cases, Candida sp. and CMV being 
the most frequent etiological agents. These findings are in 
agreement with other necropsy studies that showed changes 
in the digestive system in 82.3% of 45 necropsies and 61.2% 
of 49 necropsies3,4. Our previous necropsy study performed 
in the pre-HAART phase showed changes in the digestive 
Table 6 - Main morphological changes in 303 necropsies of AIDS patients in whom it was possible to analyze the stomach, 
according to the study group
Stomach Injuries Group A (n=171) Group B (n=80) Group C (n=52) Total (n=303)(n) % (n) % (n) % (n) %
INFECTION
CMV infection 15 8.8 3 3.7 3 5.7 21 6.9
Toxoplasmosis 9 5.3 0 0 0 0 9 3
Strongyloidiasis 2 1.2 2 2.5 3 5.7 7 2.3
Histoplasmosis 4 2.4 0 0 2 3.8 6 2
Cryptococcosis 4 2.4 1 1.2 0 0 5 1.6
H. pylori 2 1.2 2 2.5 0 0 4 1.3
Candidiasis 3 1.8 0 0 0 0 3 1
Cryptosporidiosis 2 1.2 0 0 0 0 2 0.7
NEOPLASMS
Karposi’s sarcoma 2 1.2 1 1.2 1 1.9 4 1.3
Carcinoma 1 0.6 0 0 0 0 1 0.3
GIST 0 0 1 1.2 1 1.9 2 0.7
NONINFECTIOUS ULCERS
Acute 6 3.5 2 2.5 0 0 8 2.6
Chronic Peptic 5 3.0 2 2.5 0 0 7 2.3
Nonspecific 0 0 1 1.2 0 0 1 0.3
Concomitant lesions were present in 9 cases. Group A: without using any antiretroviral medication; Group B: 1 or 2 antiretroviral 
drugs for any time or on HAART for less than the last six months; Group C: HAART in the last 6 months or more; n: number of 
cases; GIST: gastrointestinal stromal tumor; CMV‑ cytomegalovirus; X2 test; p > 0.05.
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system in 78.5% of cases17. The higher prevalence of 
infection by Candida sp.17,20,21 and CMV3,4,5,22 among other 
infectious agents, and neoplasms, have also been reported 
in necropsy and biopsy studies, both in general studies, 
and also in those solely concerning the digestive system. 
Candidiasis was the most frequent infection in this study. 
In addition to the damage to the tongue and esophagus, 
the most common sites, stomach and large intestine were 
also committed. In all of the cases analyzed, this infection 
was only located in the mucosa, with pseudo-hyphae and 
spores in areas of the squamous epithelium with hyper 
parakeratosis, or fibrin-leukocyte pseudo membranes, 
occasionally causing erosions. However, no deep invasion 
of tissues was found. In only two of these cases there was 
concomitant lung disease that caused death; neither of 
them were on HAART. In a study of esophageal biopsies 
of patients with HIV infection23, the invasion of fungi of 
the muscular and esophageal adventitia was observed, 
in addition to vascular invasion, which would allow the 
development of disseminated infections by Candida sp. 
These changes were not observed in this study. 
CMV is one of the most frequent opportunistic agents 
found in necropsy studies of the digestive system4,24,25,26. 
In this study, we found a statistically significant association 
between the occurrence of CMV and the nonuse of HAART. 
Cytomegalovirus infection was observed in all the segments 
of the digestive system, the infection being most common 
in the stomach and intestines. Cytomegalic inclusions were 
present in endothelial cells, epithelial cells and stromal 
cells of the lamina propria, associated or not with erosions 
and mucosal ulcers. In fact, clinical manifestations of 
CMV infection are variable, depending on the lesions 
in the affected tissues. In the digestive system, advanced 
disease is represented by erosion or mucosal ulceration, 
causing watery diarrhea, and the differential diagnosis 
of this condition with other causes of diarrhea in patients 
with AIDS is very difficult27, requiring histopathological 
confirmation for the definitive diagnosis. In the large 
intestine, a statistically significant association between 
CMV infection and the nonuse of HAART was noted.
Still regarding the large intestine, there was a statistically 
significant association between the occurrence of different 
types of injuries and the absence of HAART. In this study, 
there was a reduced frequency of changes in the colon in 
Table 7 - Main morphological changes in 306 necropsies of AIDS patients in whom it was possible to analyze the small intestine, 
according to the study group
Small intestine injuries Group A (n=174) Group B (n=81) Group C (n=51) Total (n=306)(n) % (n) % (n) % (n) %
INFECTION
CMV infection 13 7.5 3 3.7 2 3.9 18 5.9
Histoplasmosis 8 4.6 3 3.7 2 3.9 13 4.2
Mycobacterial infection 9 5.2 0 0 1 1.9 10 3.3
Strongyloidiasis 3 1.7 2 2.5 4 7.8 9 3
Cryptococcosis 5 2.9 2 2.5 0 0 7 2.3
Ascaridiasis 2 1.1 2 2.5 0 0 4 1.3
Toxoplasmosis 2 1.1 0 0 0 0 2 0.6
Cryptosporidiosis 1 0.6 0 0 1 1.9 2 0.6
Schistosomiasis 0 0 1 1.2 0 0 1 0.3
Teniasis 1 0.6 0 0 0 0 1 0.3
NEOPLASMS
Karposi’s sarcoma 2 1.1 0 0 1 1.9 3 1
GIST 0 0 1 1.2 0 0 1 0.3
NONINFECTIOUS ULCERS
Nonspecific 2 1.1 1 1.2 1 1.9 4 1.3
Chronic Peptic 1 0.6 0 0 0 0 1 0.3
INFARCTION 1 0.6 1 1.2 1 1.9 3 1
Concomitant lesions were present in 5 cases. Group A: without using any antiretroviral medication; Group B: 1 or 2 antiretroviral 
drugs for any time or on HAART for less than the last six months; Group C: HAART in the last 6 months or more; GIST: gastroin‑
testinal stromal tumor; CMV – cytomegalovirus; X2 test; p > 0.05.
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47.4% of patients without HAART in comparison with 
31.4% in those on HAART. Biopsy studies have shown a 
reduction in the frequency of changes in the digestive tract, 
from 38% before the introduction of HAART to 19% after 
its introduction28.
Histoplasmosis was the third most frequent infection 
(6.5%), being present in all the segments of the digestive 
system, similar to the rate found in other South American 
studies29,30. South and Central America are considered 
endemic areas for histoplasmosis13,31. A Brazilian study 
that analyzed biopsies of the digestive system showed a 
decreased histoplasmosis frequency after the introduction 
of HAART32. 
Mycobacterial infection occurred in 5.6% of cases, being 
systemic and constituting an immediate or contributory 
cause to death in all of them. Indeed, in developing 
countries, tuberculosis is still a major cause of death9,11 even 
after the introduction of HAART. Possible explanations 
include the poor adherence to treatment, drug resistance 
and late diagnosis of the disease.
Figure 1 - Survival time (in months) after the diagnosis of HIV 
infection in 297 of the 322 cases submitted to necropsy, in whom 
it was possible to obtain this information, according to the study 
group (Kaplan‑Meier test)
Table 8 - Main morphological changes in 301 necropsies of AIDS patients in whom it was possible to analyze the large intestine, 
according to the study group
 
Large intestine injuries Group A (n=173) Group B (n=77) Group C (n=51) Total (n=303)
(n) % (n) % (n) % (n) %
INFECTION
CMV infection 27* 15.6 6 7.8 2* 4 35 11.6
Histoplasmosis 10 5.8 4 5.2 2 4 16 5.3
Mycobacterial infection 12 7 2 2.6 0 0 14 4.6
Strongyloidiasis 5 2.9 1 1.3 3 5.9 9 3
Cryptococcosis 4 2.3 2 2.6 1 2 7 2.3
Toxoplasmosis 3 1.7 1 1.3 0 0 4 1.3
Candidiasis 3 1.7 0 0 0 0 3 1
Paracoccidioidomycosis 2 1.2 0 0 1 2 3 1
Schistosomiasis 1 0.6 1 1.3 0 0 2 0.7
Teniasis 1 0.6 1 1.3 0 0 2 0.7
Cryptosporidiosis 1 0.6 0 0 0 0 1 0.3
Isosporiasis 1 0.6 0 0 0 0 1 0.3
Chagasic Megacolon 0 0 0 0 1 2 1 0.3
NEOPLASMS
Karposi’s sarcoma 1 0.6 0 0 0 0 1 0.3
Carcinoma 0 0 1 1.3 0 0 1 0.3
Lipoma 1 0.6 0 0 0 0 1 0.3
NONINFECTIOUS ULCERS 3 1.7 2 2.6 3 5.9 8 2.6
INFARCTION 2 1.2 1 1.3 1 2 4 1.3
Concomitant injuries were present in 12 cases. Group A: without using any antiretroviral medication; Group B: 1 or 2 antiretroviral 
drugs for any time or on HAART for less than the last six months; Group C: HAART in the last 6 months or more; n: number of 
cases; CMV – cytomegalovirus; *Fisher’s exact test; p < 0.05.
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Analyzing the whole digestive system, T. gondii was 
found in 4.3% of cases in this study and there was a 
statistically significant association between toxoplasmosis 
and the nonuse of HAART. On the other hand, a Brazilian 
clinical study showed an increased toxoplasmosis frequency 
in the post-HAART phase when biopsies of the digestive 
system were analyzed, and the increment was attributed 
to the use of more accurate diagnostic methods32. The 
frequency of toxoplasmosis in necropsy studies is quite 
variable, ranging from a total absence of infection3,4 to rates 
of up to 26% in areas with high prevalence of T. gondii 
infection20. In Brazil, the prevalence of anti-Toxoplasma 
antibodies in the general population ranges from 50 to 
80%33. In AIDS, immunodeficiency favors the endogenous 
reactivation of the agent and the emergence of disseminated 
forms of the disease, affecting even the digestive system. 
Chagas disease, a common infection in the area of this 
study, was observed in two cases: one with megaesophagus 
and the other with megaesophagus and megacolon; neither 
of them presented reactivation of Chagas disease, a 
condition that is related to AIDS. 
In several necropsies, the association of different 
infectious agents and tumors in the same segment or in 
different segments of the digestive system was observed. 
Similar conditions were found in 37.7% of cases in another 
study of AIDS patients who evolved to death and had their 
digestive systems studied after necropsy3. The coexistence 
of different conditions highlights the fact that even after the 
diagnosis of an opportunistic infection, one should not stop 
searching for other possible etiologies21. 
Among the malignancies found in this study, only 
Kaposi’s sarcoma is related to AIDS, having been found 
in all the segments studied, except in the tongue, in a total 
of 5 cases (2.1%). None of the other malignancies found 
(3 GIST, 3 carcinomas – 1 gastric adenocarcinoma cells in 
signet ring, 1 metastatic undifferentiated carcinoma of the 
testis, 1 rectal squamous cell carcinoma) are considered to 
be related to AIDS. The low incidence of malignancies also 
occurred in other necropsy studies, not only in Brazil3,29,34,35, 
but also in foreign studies that analyzed necropsy and biopsy 
samples9,21. 
In developed countries, the incidence of neoplasms 
unrelated to AIDS has increased after the introduction of 
HAART due to the higher survival and aging of patients36. 
Several foreign studies reported malignancies as, currently, 
one of the leading causes of death in AIDS patients, along 
with other causes unrelated to AIDS, such as drug overdose, 
suicide, violence, liver and cardiovascular diseases8,37,38,39. 
In recent reports of the post-HAART era, statistically 
significant increments were observed in the frequencies of 
gastroesophageal reflux disease, digestive inflammatory 
diseases, gastric ulcer and Helicobacter pylori infection21,40. 
These studies were carried out using biopsy samples. With 
necropsy material, as in the present study, autolysis hinders 
the diagnosis of Helicobacter pylori and Cryptosporidium 
infection, agents that infect the mucosal surface, as well 
as of HIV enteropathy, reflux esophagitis and gastritis. 
Gastric peptic ulcers were present in seven patients and 
duodenal peptic ulcers in one case; however, without 
significant association in any of the studied groups. 
Idiopathic esophageal ulcers (without identified infectious 
agents) were noted in 19 (7%) patients. Nkuize et al.40 
observed a reduction in Candida sp. esophagitis frequency, 
nonspecific esophageal ulcers and Kaposi’s sarcoma over 
17 years of study. The same authors reported the presence 
of Candida sp. esophagitis in 16% of patients on HAART. 
Another study using biopsy material showed a prevalence 
of 9% of opportunistic infections in AIDS patients on 
HAART41. These authors attributed this finding mainly to 
the non-adherence to treatment, which occurred in 40% of 
cases. In patients whose treatment was carried out correctly, 
possible causes for the occurrence of opportunistic 
infections despite HAART include viral resistance to 
anti-HIV drugs, drug interactions, and decreased drug 
bioavailability. 
Regarding the relevance of digestive system diseases 
to the death of patients, it was observed that only in 4.3% 
of cases these changes were the cause, or a contributory 
factor to death. In fact, diseases of the digestive system 
are important causes of morbidity and decreased quality of 
life in patients with AIDS, being among the most frequent 
diseases in these patients21.
We conclude that, in this study, analyzing the whole 
digestive system, there was a decreased frequency of 
toxoplasmosis and CMV in the group treated with HAART 
compared with the group without antiretroviral treatment. 
In the analysis made according to the digestive system 
segment, only in the large intestine, and only with respect 
to CMV infection, there was a frequency reduction in the 
group on HAART compared with the group without the use 
of antiretroviral drugs. Our results confirm that the digestive 
system is a common site of disease related to HIV/AIDS, 
even with the introduction of HAART, although digestive 
diseases are uncommon causes of death in these patients. 
The longer survival time of HAART users shows a clear 
benefit of HAART, corroborating clinical studies. 
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